Its clear that GLP-1 receptor agonists can affect mental health in complex ways
Outside of shortages, compounding pharmacies routinely provide medicines that arent otherwise available or need to be tailored to a particular patient
At week 24, about half of the DD01 group achieved 5 percent or greater weight loss, and HbA1c levels decreased significantly compared with placebo
As reported in the journal Radiology , among the men with a thrombus, the AAAs were larger at baseline, compared with those who did not have a thrombus
Novo Nordisk is one of two pharma companies that are currently selling branded GLP-1 treatments
Red flags that suggest problematic marketing include: claims of pharmaceutical equivalence ("works just like Ozempic"), rapid weight loss promises (dramatic outcomes in short timeframes), proprietary blends without strain disclosure, astronomical CFU counts emphasized over strain quality, and unrealistic guarantee windows preventing adequate assessment